Antigen-specific immunotherapy and, in particular, DNA vaccination provides an established approach for tackling human papillomavirus (HPV) cancers at different stages. DNA vaccines are stable and have a cost-effective production. Their intrinsic low immunogenicity has been improved by several strategies with some success, including fusion of HPV antigens with plant gene sequences. Another approach for the control of HPV cancers is the use of natural immunomodulatory agents like those derived from plants, that are able to interfere in carcinogenesis by modulating many different cellular pathways and, in some instances, to reduce chemo- and radiotherapy resistance of tumors. Indeed, plant-derived compounds represent, in many cases, an abundantly available, cost-effective source of molecules that can be either harvested directly in nature or obtained from plant cell cultures. In this review, an overview of the most relevant data reported in literature on the use of plant natural compounds and genetic vaccines that include plant-derived sequences against HPV tumors is provided. The purpose is also to highlight the still under-explored potential of multimodal treatments implying DNA vaccination along with plant-derived agents.
|Titolo:||Plant-derived natural compounds in genetic vaccination and therapy for HPV-associated cancers|
|Data di pubblicazione:||2020|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto:
|Plant-Derived Natural Compounds in Genetic Vaccination and Therapy for HPV-Associated Cancers.pdf||Versione Editoriale (PDF)||Open Access Visualizza/Apri|